|
|
As part of the dual listed company structure, Investec plc and Investec Limited (together the "Investec Group") notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules, and Listing Rules of the Financial Conduct Authority (the "FCA") and/or the JSE Listings Requirements.
Accordingly we advise of the following:
Director Declaration
In accordance with Listing Rule 9.6.14R, the Investec Group announces that Fani Titi, Chief Executive of the Investec Group, will not stand for re-election at the Annual General Meetings ("AGMs") of Ninety One plc and Ninety One Limited (together "Ninety One"), and will accordingly step down as a non-executive director from the Ninety One Board on 04 August 2021.
Pursuant to the relationship agreement entered into with Ninety One, Khumo Shuenyane, an independent non-executive director of the Investec Group, has been selected to succeed Fani as the Investec Group representative on the Ninety One Board. Khumo will accordingly be appointed a non-executive director of Ninety One with effect from 01 August 2021.
In accordance with Listing Rule 9.6.14R, the Investec Group further announces that Zarina Bassa, Senior Independent Director of the Investec Group, will be appointed as non-executive director of Mediclinic International plc with effect from 01 February 2022.
London and Johannesburg
28 July 2021
Sponsor:
Investec Bank Limited